Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESOLVE: S8 Sinus Implant for Recurrent Nasal Polyps
NCT01732536Phase 3Completed
- Sponsor
- Intersect ENT
- Start
- Jan 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mometasone furoate nasal spray in sinusitis and nasal polyps (2 arms), sponsored by Intersect ENT. Primary endpoints: Nasal Obstruction/Congestion Score at 90 days and Bilateral Polyp Grade at 90 days. Started Jan 2013; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
sinusitisnasal polyps
Beyond the preview
Go deeper on NCT01732536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01732536.